Today's employers face a significant challenge: containing the ever-rising costs of employee healthcare benefits. A recent study shows that 89% of employers are taking one or more actions to lower their healthcare costs. To achieve the right results at the right price, employers are revisiting their requirements and redefining their expectations. Read the full market brief to learn how Dario can help facilitate a successful transition. The brief will also dive into one customer's journey to better outcomes with our cost-effective solution. 🔗 Link in the comments to download.
DarioHealth
Wellness and Fitness Services
New York, New York 21,007 followers
Digital Health Solutions for Chronic Conditions
About us
DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com. Our Mission: We make it easy for people to care for their health, with continuous and connected support that anticipates needs, understands motivation, and simplifies behavior change to put better health and outcomes in everyone’s reach. Investors, please visit Investors, please visit: https://dariohealth.investorroom.com/Welcome
- Website
-
http://www.dariohealth.com/
External link for DarioHealth
- Industry
- Wellness and Fitness Services
- Company size
- 201-500 employees
- Headquarters
- New York, New York
- Type
- Public Company
- Founded
- 2011
- Specialties
- Diabetes management, digital health, Digital Therapeutics, Hypertension management, Employee Benefits, Behavioral Health, Chronic Condition Management, Prediabetes, MSK , and Weight Management
Locations
-
Primary
18 W. 18th Street
New York, New York 10011, US
-
8 Hatokhen Street
North Industrial Park
Caesarea, Caesarea 3088900, IL
-
Gurugram, Haryana 122001, IN
Employees at DarioHealth
Updates
-
Catch DarioHealth Chief Medical Officer, Omar Manejwala, M.D. and Floreo Chief Medical Officer Benjamin A. tomorrow at 10:00 am CDT discussing recent trends in mental health mergers and acquisitions. This meeting will dive deep into the strategic alliances, partnerships, and acquisitions reshaping the delivery of mental health services in the digital age. https://hubs.li/Q02KZNh60
-
-
We're excited to share today the reported financial results for the second quarter 2024. In the second quarter, we drove significant growth in our core business-to-business-to-consumer (B2B2C) channel. Our B2B2C channel grew 60% sequentially over the first quarter of 2024, and 315% over the second quarter of 2023, primarily due to Aetna customer sign on, expansions of existing customer contracts, new customer launches, and the addition of Twill, Inc. ("Twill") revenues following our acquisition of Twill in the first quarter of 2024. The organic sequential growth of this channel is 28%. Our legacy direct to consumer (B2C) business remains at its consistent run rate at $7.6 million. The link to the press release and research results can be found in the comments below.
-
-
*Reminder: DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th We will be releasing the financial results for the 2nd quarter that ended on June 30th, 2024, on Thursday, August 8th, 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time. Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call.
-
Check out our Chief Medical Officer, Omar Manejwala, M.D. talk about how DarioHealth helps employers support employees with chronic conditions, the advancement of the platform after the Twill acquisition, and expansion of reach with Medicaid. #Dario #digitalhealth
Supporting multiple conditions using one digital therapeutic
mobihealthnews.com
-
In this edition of Dario Digital Digest, we delve into how we support our members in achieving diabetes remission. Our Cardiometabolic Solution equips members with the tools needed for effective weight loss, increased physical activity, and proper diet management. #Dario #DigitalHealth #DiabetesRemission
Helping Members Achieve Diabetes Remission
DarioHealth on LinkedIn
-
Proud to be recognized as a leader in the digital health market as one of the world's best digital health companies in 2024. #Dario #Dariohealth #digitalhealth
World's Best Digital Health Companies 2024
newsweek.com
-
We are excited to share our latest findings and insights on helping members achieve diabetes remission. Our comprehensive approach is designed to support members on their journey to better health outcomes. Read more in our latest executive brief - link is available in the comments. #digitalhealth #dario
-
-
We're excited to share a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the third quarter of 2024. The employer, a leader in environmental services, selected Dario’s cardiometabolic suite to address multiple health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including integrated support for those employees taking a GLP-1 medication. Dario’s proven ability to drive sustainable behavior change is key to helping employees achieve successful outcomes while taking a GLP-1, as research shows that 68% of people stop taking these medications within a year, putting them at high-risk of regaining the weight lost. The link to the press release and research results can be found in the comments below.
Dario Expands GLP-1 Solution Client Base with New Employer Contract - DarioHealth
dariohealth.com